Dementia 97% higher with HAART

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

PaulKing - 09 Oct 2004 04:39 GMT

“…HIV dementia among those reporting any antiretroviral use (AZT, ddI, ddC,
or d4T) was 97% higher than among those not using this antiretroviral
therapy…the findings… seem to confirm…a neurotoxic effect of
antiretroviral agents. Numerous studies have linked the use of ddI, ddC,
and d4T to the development of toxic sensory neuropathies, usually in a
dose-response fashion.”

Neurology 1994; 44: 1892-1900

NOTE. That explains Mr. Carter

Reply to this Message

GMCarter - 09 Oct 2004 11:22 GMT

LOL. Your re line is WRONG!!!!

High central nervous system HIV load is related to the development of
dementia. ARV brings the load down. Dementia is reduced in incidence.

Unfortunately, ARV drugs like ddI, ddC and d4T have effects on
PERIPHERAL nerves and cause neuropathy in many. Acetylcarnitine may
help offset this problem, along with alpha lipoic acid, B complex,
etc.

Learn to read.
George M. Carter

>HIV dementia among those reporting any antiretroviral use (AZT, ddI, ddC,
>or d4T) was 97% higher than among those not using this antiretroviral
[quoted text clipped - 6 lines]
>
>NOTE. That explains Mr. Carter

Reply to this Message